ID

20229

Descrição

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Palavras-chave

Versões (2)
  1. 15/02/2017 15/02/2017 -
  2. 20/02/2017 20/02/2017 -
Transferido a

15 de fevereiro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

  • Os mais recentes
  • Os mais antigos
  • Preferidos
  • Os mais recentes
    • Os mais recentes
    • Os mais antigos
    • Preferidos

Sem comentários

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Inglês

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulários  
Toast Criteria
Descrição

Toast Criteria

1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
Descrição

Etiologic subtype

Tipo de dados

integer

Concomitant Medication
Descrição

Concomitant Medication

Alias
UMLS CUI-1
C2347852
2. Are any medications listed below currently being taken on the day of visit 1?
Descrição

Medication taken

Tipo de dados

boolean

If yes, please indicate which, if any, of the following are currently being taken:
Descrição

If the patient is taking any restricted (bolded) concomitant medications (see facing page), please ensure these are stopped prior to randomasation.

Tipo de dados

integer

ACE Inhibitors
Descrição

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
3. Are ACE Inhibitors currently being taken on the day of visit 1?
Descrição

ACE Inhibitors currently taken

Tipo de dados

boolean

Name of ACE Inhibitor and Total Daily Dose
Descrição

Name of ACE Inhibitor and Total Daily Dose

Tipo de dados

text

Voltar ao início da página

Similar models

Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Toast Criteria
Item
1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
integer
Etiologic subtype
Code List
1. For the qualifying stroke, please categories the ethnologic below (indicate one only)
CL Item
Large-artery atherosclerosis (1)
CL Item
Cardioembolism (2)
CL Item
Small-artery occlusion (lacune) (3)
CL Item
Acute stroke of other determined etiology (4)
CL Item
Stroke of underdetermined etiology (5)
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Medication taken
Item
2. Are any medications listed below currently being taken on the day of visit 1?
boolean
Item
If yes, please indicate which, if any, of the following are currently being taken:
integer
If yes, please indicate which
Code List
If yes, please indicate which, if any, of the following are currently being taken:
CL Item
Dipyridamole (0)
CL Item
Aspirin (1)
CL Item
Ticlopidine (2)
CL Item
Clopidogrel (3)
CL Item
Aspirin/extended release Dipyridamole (4)
CL Item
Oral anticoagulants (5)
CL Item
Nitrates (oral or topical) (6)
CL Item
Estrogen replacement without progesterone (7)
CL Item
Estrogen replacement with progesterone (8)
CL Item
Digitalis (9)
CL Item
Statins (10)
CL Item
Fibrates (11)
CL Item
Dilitazem/Verapamil (12)
CL Item
Other calcium channel blockers (13)
CL Item
Alpha-blocker (14)
CL Item
Direct vasodilators (15)
CL Item
Angiotensin Receptor Blocker (ARB) (16)
CL Item
Peripheral sympatholytic (17)
CL Item
Central sympatholytic (18)
CL Item
Alpha-beta blocker (19)
CL Item
Beta-blocker (20)
CL Item
Loop-active diuretics (21)
CL Item
Diuretics of thiazide type (22)
CL Item
Potassium-sparing diuretics (23)
CL Item
Insulin (24)
CL Item
Oral hypoglycemic agents (25)
CL Item
Non-steroidal anti-inflammatory drugs (26)
CL Item
Specific Cox II inhibitors (27)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
3. Are ACE Inhibitors currently being taken on the day of visit 1?
boolean
Name of ACE Inhibitor and Total Daily Dose
Item
Name of ACE Inhibitor and Total Daily Dose
text
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial